Business Context and Reporting Period
This Form 8-K was filed by Corbus Pharmaceuticals Holdings, Inc. on January 3, 2022. The report addresses a regulatory notice received from The Nasdaq Stock Market regarding the company's compliance with listing standards.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the status of the company's stock listing.
Material Changes
The material event reported is the receipt of a notice from Nasdaq indicating that the company's common stock has failed to maintain a minimum closing bid price of $1.00 per share for the last 30 consecutive business days. This non-compliance is based on Nasdaq Listing Rule 5550(a)(2).
Outlook, Risks, and Contingencies
- Compliance Period: The company has been granted an initial 180-day compliance period, ending July 5, 2022, to regain compliance.
- Remediation Path: Compliance can be achieved if the stock closes at or above $1.00 per share for 10 consecutive business days before the deadline.
- Secondary Option: If the initial period expires without compliance, Nasdaq may grant a second 180-day period if the company transfers to the Nasdaq Capital Market and meets other listing standards.
- Risk of Delisting: Failure to regain compliance within the allotted periods may result in delisting. The company retains the right to appeal a delisting determination to a Nasdaq hearings panel.
- Current Status: The notice has no immediate effect on the listing status, and the stock remains fully effective on the Nasdaq Global Market.
Investor Verification Checklist
- Verify the current closing bid price of Corbus Pharmaceuticals Holdings, Inc. (CRBP) to assess proximity to the $1.00 threshold.
- Monitor the company's stock performance over the next 10 consecutive business days to determine if the initial compliance window is met.
- Review future filings for updates on the company's intent to transfer to the Nasdaq Capital Market if the first compliance period is unsuccessful.
- Check for any subsequent announcements regarding the extension of the compliance period or potential delisting notices.